Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Dermatology indexChapter sections
Purpose and principlesIndications, selection and cautionsMethod and interpretationClinical next stepsRisks, monitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook9 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Punch, shave and excision biopsy principles

Dermatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Time-critical presentation

Escalate urgently when assessment for Punch, shave and excision biopsy principles reveals systemic toxicity, airway or eye involvement, extensive skin failure, a non-blanching eruption in an unwell patient, or a rapidly changing lesion suspicious for aggressive malignancy.

Purpose and principles

Choose punch, shave or excision biopsy according to the clinical question, obtain informed consent and a representative specimen, and prevent avoidable diagnostic and procedural harm.

Biopsy is a diagnostic intervention, not a neutral sample. Select a fresh representative lesion and the area containing the discriminating process: active edge for some inflammatory eruptions, intact blister plus separate perilesional tissue for immunofluorescence, or the most suspicious area of a heterogeneous tumour. Discuss the plan with dermatopathology when site or transport is uncertain.

Explain pain, bleeding, infection, scarring, pigment change, numbness, wound separation, incomplete diagnosis and the possibility of further treatment. Local anaesthetic and haemostasis must suit anatomy and comorbidity. Label specimen and request form together, including exact site, duration, morphology, differential and treatment.

Punch, shave and excision biopsy principles should answer a defined clinical question and be integrated with history, examination and the consequences of error. Explain uncertainty, record the sampling or observation conditions, and arrange a result-review plan rather than treating an isolated finding as self-interpreting.

Key points

  • Plan with the reporting question and suspected depth in mind: technique, site and orientation determine what the pathologist can assess.
  • Excision with an appropriate narrow clinical margin is generally used for suspected melanoma diagnosis when feasible; avoid superficial shave sampling that truncates depth.
  • Punch biopsy provides full-thickness cylindrical tissue from a selected focus, while shave biopsy samples superficial exophytic or epidermal lesions.
  • Confirm identity, allergies, anticoagulants, implanted devices, pregnancy where relevant, anatomical risk, consent, specimen container and result ownership before starting.
  • For Punch, shave and excision biopsy principles, describe what is seen before assigning a diagnosis, and record site, extent, symptoms, duration and change over time.
  • A technically adequate result in Punch, shave and excision biopsy principles can still be misleading when the wrong lesion, site, preparation or clinical question was selected.

Indications, selection and cautions

Need for depth

Induration, nodularity, suspected invasive tumour, panniculitis or deep inflammation requires a technique that includes the relevant dermis or subcutis.

Superficial target

A clearly benign-appearing exophytic or superficial epidermal lesion may be suited to shave sampling when histological depth is not decisive.

Melanoma concernRed flag

Asymmetry, evolution, nodularity, ulceration or atypical pigment should trigger a melanoma-appropriate excision or specialist pathway.

Vascular and neural anatomy

Face, digits, genital skin and sites over named vessels or nerves demand technique-specific anatomical caution.

Clinicopathological discordance

A benign report that does not explain a changing or suspicious lesion requires review of site, images and sampling adequacy.

Red flags requiring action

  • Suspected melanoma, rapidly growing squamous malignancy, uncontrolled bleeding risk, infection at the procedural site or a lesion near critical anatomy requires appropriate specialist planning rather than an improvised biopsy.

Method and interpretation

  1. 01
    Pre-procedure history and examinationFirst step
    Why
    Choose a safe technique and representative target.
    Interpretation and limitations
    Review bleeding medicines, allergies, healing risk, infection, implanted devices and suspected diagnosis; anticoagulants are not stopped automatically.
  2. 02
    Punch biopsy
    Why
    Acquire epidermis and dermis, sometimes superficial fat, from a selected small site.
    Interpretation and limitations
    Diameter and depth must match pathology; a punch through the wrong part of a heterogeneous lesion can miss invasion or diagnostic edge.
  3. 03
    Shave biopsy
    Why
    Remove a superficial raised or epidermal lesion efficiently.
    Interpretation and limitations
    A shave can be adequate for selected lesions but may transect deeper pathology and is unsuitable when accurate tumour depth is required.
  4. 04
    Excision biopsy
    Why
    Remove a whole small lesion for architectural and margin assessment.
    Interpretation and limitations
    Orient, measure and label the specimen; diagnostic excision does not eliminate the need for definitive wider treatment if malignancy is found.
  5. 05
    Histology request and transport
    Why
    Preserve tissue and give the pathologist decisive clinical context.

Clinical next steps

01Planned assessmentUse skin biopsy planning systematicallyFirst stepThe patient is stable and the result will alter diagnosis, referral or follow-up.+
  1. 1Define the question for Punch, shave and excision biopsy principles, explain the process and obtain valid consent before exposing, touching, photographing or sampling skin.
  2. 2Choose representative anatomy, optimise lighting or specimen technique, and document site, morphology, symptoms and relevant previous treatment. Apply that step specifically within the punch, shave and excision biopsy principles assessment and its recorded clinical context.
  3. 3Interpret the result beside the full clinical pattern, communicate uncertainty and arrange ownership of results and safety-netting. Apply that step specifically within the punch, shave and excision biopsy principles assessment and its recorded clinical context.
02Uncertain resultResolve discordance in Punch, shave and excision biopsy principlesThe technical finding conflicts with the history, lesion evolution or wider examination.

Risks, monitoring and follow-up

  • Record who will review the result arising from Punch, shave and excision biopsy principles, the expected timescale and the action threshold before the patient leaves.
  • Compare subsequent findings with the original site description, dimensions, symptoms and image or specimen identifiers for Punch, shave and excision biopsy principles.
  • Reassess earlier if rapid growth, bleeding, ulceration, fever, mucosal disease, eye symptoms or functional compromise develops. Apply that step specifically within the punch, shave and excision biopsy principles assessment and its recorded clinical context.
  • Document technical limitations and previous treatment that could alter sensitivity or specificity of skin biopsy planning.
  • Close the loop after specialist or laboratory review, including clinicopathological disagreement and any need for repeat sampling. Apply that step specifically within the punch, shave and excision biopsy principles assessment and its recorded clinical context.

Special situations

Biopsy the question

The correct technique is determined by what must be demonstrated or excluded, not simply by lesion diameter.

Edges and centres differ

Inflammatory borders, ulcers and tumours contain heterogeneous pathology, so site choice should be recorded with an image or diagram.

Two samples may be needed

Routine histology and direct immunofluorescence require differently targeted specimens and incompatible transport arrangements.

A report samples reality

Histology describes submitted tissue; it cannot exclude disease that lay deeper or elsewhere in the lesion.

Aftercare is diagnostic safety

A result recall system and review of non-healing wounds matter as much as suture and dressing instructions.

Common pitfalls

  1. 01

    Using a superficial shave for a lesion in which melanoma depth and architecture are clinically important.

  2. 02

    Placing a direct-immunofluorescence specimen in formalin and destroying the intended test.

  3. 03

    Stopping anticoagulation reflexively without balancing procedural bleeding against thrombotic risk and local guidance.

  4. 04

    Sending tissue as skin lesion without precise site, morphology, duration or differential diagnosis.

  5. 05

    Accepting a discordant benign result while the photographed lesion continues to enlarge or ulcerate.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
DermatologyOriginal SBA

Suspected melanoma sample

A changing asymmetric pigmented lesion is small enough for complete removal and melanoma is suspected. Which diagnostic approach is most appropriate when anatomically feasible?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Dermatology topics →
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • Guy's and St Thomas' NHS Foundation Trust skin biopsySkin-biopsy preparation, procedure, aftercare and result follow-up.
  • NICE NG14 melanoma assessment and managementDermoscopy, baseline photography and specialist assessment recommendations.
  • NICE NG12 suspected cancer recognition and referralUrgent referral features for suspected skin malignancy.
  • Worcestershire Acute Hospitals direct immunofluorescencePerilesional selection and special transport-medium requirements.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
Interpretation and limitations
Routine histology uses formalin, whereas immunofluorescence needs a separate specimen and transport medium specified by the receiving laboratory.
+
  1. 1Recheck identity, site, timing, preparation, treatment exposure and whether the selected target was genuinely representative. Apply that step specifically within the punch, shave and excision biopsy principles assessment and its recorded clinical context.
  2. 2Repeat or select a complementary test only when it can distinguish the remaining important alternatives. Apply that step specifically within the punch, shave and excision biopsy principles assessment and its recorded clinical context.
  3. 3Seek dermatology, pathology, microbiology or allergy advice when clinicopathological disagreement would change urgent care. Apply that step specifically within the punch, shave and excision biopsy principles assessment and its recorded clinical context.
03Urgent patternDo not let skin biopsy planning delay escalationEscalationA rapidly progressive eruption, systemic illness, threatened vision or airway, or suspected aggressive malignancy is present. Apply that step specifically within the punch, shave and excision biopsy principles assessment and its recorded clinical context.+
  1. 1Stabilise immediate physiological threats and obtain same-day senior or specialty assessment according to the dominant emergency. Apply that step specifically within the punch, shave and excision biopsy principles assessment and its recorded clinical context.
  2. 2DefinitiveTake time-critical images or specimens only when doing so will not postpone resuscitation, antimicrobials or definitive referral. Apply that step specifically within the punch, shave and excision biopsy principles assessment and its recorded clinical context.
  3. 3Record evolution and communicate the differential, outstanding results and explicit deterioration triggers during handover. Apply that step specifically within the punch, shave and excision biopsy principles assessment and its recorded clinical context.